Home Situations SMMT — Weak businesses rallying
Situation · 2026-04-24

SMMT — Weak businesses rallying

Discounted for a Reason: Summit’s Business Gap

Updated 2026-04-24 · Ref: Biotechnology
Key metrics — 2026-04-24
Peer score
34
Quality pct
35
Valuation pct
30
52w drawdown
-39.8%
21d vs sector
+26.1%
Peer group
Biotechnology
Situation summary

Summit trades at a discount because there is no product revenue. The stock is a bet on FDA approval, not a business. 90% volatility says it all. Until approval, the discount is deserved.

Published by AssetNext · 2026-04-23

All companies with this signal today

View full list: Weak businesses rallying →

Related pages for SMMT
Full peer analysis for Summit Therapeutics Inc. →Similar companies to SMMTSMMT peersAll SMMT comparisonsRussell 1000 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-04-22 Weak businesses rallying 34 -33.0% +57.7%
2026-04-20 Weak businesses rallying 34 -31.6% +59.2%
2026-04-16 Weak businesses rallying 34 -33.5% +58.3%
2026-04-13 Weak businesses rallying 34 -45.4% +32.2%
2026-04-09 Weak businesses rallying 34 -47.4% +22.4%
2026-04-06 Weak businesses rallying 34 -49.1% +28.1%
2026-04-02 Weak businesses rallying 34 -47.2% +30.7%
2026-03-31 Weak businesses rallying 34 -48.3% +23.3%

See SMMT's full peer analysis

Break down SMMT's structural position across all peer dimensions with the interactive app.

Open SMMT in AssetNext →